|
GB201220242D0
|
|
Antibody
|
|
WO2010097625A1
|
|
Diagnostic method and kit
|
|
GB0922730D0
|
|
Assay method
|
|
GB0922553D0
|
|
Prognostic marker
|
|
GB0906115D0
|
|
Antibody and uses thereof
|
|
GB0903260D0
|
|
Diagnostic method and kit
|
|
GB0903168D0
|
|
Diagnostic method and kit
|
|
GB0902916D0
|
|
Antibody therapy
|
|
GB0823657D0
|
|
Assay Method
|
|
GB0816561D0
|
|
Peptides and uses thereof
|
|
GB0812277D0
|
|
Antibody and uses thereof
|
|
GB0807018D0
|
|
Antibodies and treatment
|
|
NZ576119A
|
|
Combination therapy involving egf inhibitors
|
|
AU2007306139A1
|
|
Combination therapy
|
|
GB0716915D0
|
|
Assay method
|
|
GB0716070D0
|
|
Diagnostic method and kit
|
|
GB0711226D0
|
|
Assay method
|
|
GB0711228D0
|
|
Treatment method
|
|
NZ571985A
|
|
Therapy targeting Cathepsin S
|
|
GB0621848D0
|
|
Assay method
|
